Literature cited
G. Ya. Avrutskii and A. A. Neduva, Treatment of Patients with Mental Illness [in Russian], Moscow (1981).
N. I. Andreeva, R. G. Glushkov, and M. D. Mashkovskii, Khim.-farm. Zh., No. 4, 111–114 (1979).
N. I. Andreeva and M. D. Mashkovskii, Farmakol. Toksikol., No. 2, 133–137 (1980).
N. I. Andreeva and S. A. Sharova, ibid., No. 6, 664–667.
N. I. Andreeva, Collection of Transactions of the All-Union Chemicopharmaceutical Scientific Research Institute [in Russian], No. 9 (1982), pp. 95–100.
N. I. Andreeva, Vses. Nauchno-Issled. Inst. Med. Med.-Tekh. Inf. (VNIIMI). Rapid Information. New Drugs [in Russian], No. 5, 18–20 (1983).
O. L. Verstakova, L. N. Gerchikov, T. A. Gus'kova, et al., Farmakol. Toksikol., No. 4, 93–103 (1985).
V. S. Volkov, Yu. M. Pozdynakov, V. F. Vinogradov, and A. I. Zain'kovskii, Klin. Med., No. 3, 23–27 (1983).
R. G. Glushkov, L. G. Vasil'evykh, Z. S. Kogan, and V. S. Gorkin, Khim.-farm. Zh., No. 5, 58–62 (1981).
T. A. Gus'kova, S. S. Liberman, L. N. Gerchikov, et al., Collection of Transactions of the All-Union Chemico-pharmaecutical Scientific Research Institute [in Russian], No. 9 (1982), pp. 102–103.
V. F. Desyatnikov and K. T. Piskova, Klin. Med., No. 7, 118–122 (1980).
E. D. Krasik, L. Ya. Shemetova, and V. I. Zapuskalov, VNIIMI. Rapid Information. New Drugs [in Russian], No. 10, 20–21 (1984).
S. S. Liberman, E. F. Egorova, and S. A. Sharova, Farmakol. Toksikol., No. 1, 18–21 (1974).
V. F. Matveev, V. N. Prokudin, L. M. Bardenshtein, and A. S. Kurashov, VNIIMI. Rapid Information. New Drugs [in Russian], No. 5, 11–18 (1979).
M. D. Mashkovskii and A. I. Polezhaeva, Zh. Nevropatol. Psikhiatr., No. 8, 964–971 (1959).
M. D. Mashkovskii and L. F. Roshchina, ibid., No. 7, 1047–1051 (1981).
M. D. Mashkovskii and N. I. Andreeva, ibid., No. 4, 410–413 (1984).
N. M. Mikhailova and A. A. Severnyi, New Psychotropic Agents [in Russian], L'vov (1978), pp. 70–74.
G. P. Panteleeva, B. S. Belyaev, K. E. Borisova, and A. A. Severnyi, Antidepressants and Nootropes [in Russian], Leningrad (1982), pp. 42–48.
L. F. Roshchina, Farmakol. Toksikol., No. 4, 349–352 (1980).
A. B. Smulevich, V. Ya. Gindikin, A. S. Avedisova, et al., Zh. Nevropatol. Psikhiatr., No. 4, 594–599 (1985).
B. A. Tashmatov, K. B. D'yakovetskaya, D. S. Alieva, et al., Clinical Neurology of Uzbekistan [in Russian], No. 3, Tashkent (1975), pp. 221–224.
V. I. Fedortsov and A. N. Zavarzina, VNIIMI. Rapid Information. New Drugs [in Russian], No. 8, 18–23 (1982).
P. Bass and M. A. Patterson, J. Pharmacol. Exp. Ther.,156, 142–149 (1967).
G. M. Everett, L. L. Blockes, and G. M. Shepperd, Science,124, 79 (1956).
D. R. Gander and D. H. Brendan, Br. Med. J.,1, 1160 (1963).
P. R. Golds, F. R. Przyslo, and P. G. Strange, Br. J. Pharmacol.,68, 541–549 (1980).
C. D. Holdsworth, M. Atkinson, and W. Goldie, Lancet,16, 621–623 (1961).
P. A. P. Janssen and A. G. Jageneau, J. Pharm. Pharmacol.,9, 381–399 (1957).
W. Lippman, Arch. Int. Pharmacodyn.,193, 340–351 (1971).
R. T. Meyer, B. L. Cummings, P. Bass, and H. O. J. Collier, J. Med. Chem.,8, 515–519 (1965).
K. Opitz and A. Akinlaja, Psychopharmacologia,9, 307–319 (1966).
P. Pulewka, Arch. Exp. Pharmakol.,168, 307–309 (1932).
R. Samanin, C. Bendotti, S. Bernasconi, et al., Eur. J. Pharmacol.,43, 117–124 (1977).
P. S. J. Spencer, Br. J. Pharmacol.,25, 441–455 (1965).
J. Spengler and P. Waser, Arch. Exp. Path. Pharmakol.,237, 171–185 (1959).
W. Theobald, C. Buch, L. A. Kunz, et al., Arch. Int. Pharmacodyn.,148, 560–598 (1964).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 22, No. 3, pp. 261–271, March, 1988
Rights and permissions
About this article
Cite this article
Andreeva, N.I., Gus'kova, T.A., Mashkovskii, M.D. et al. The antidepressant incazane. II. General pharmacological properties and toxicological characteristics. Pharm Chem J 22, 181–190 (1988). https://doi.org/10.1007/BF00758265
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00758265